Bhagiradha Chemicals & Industries Limited has informed the Exchange regarding Board meeting held on May 13, 2025.
BHAGCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Bhagiradha Chemicals, at its meeting on May 13, 2025, approved converting approximately Rs. 368 Crores of loans (including accrued interest) given to its wholly owned subsidiary, Bheema Fine Chemicals Private Limited, into equity shares. The subsidiary, which manufactures and sells agrochemicals and intermediates, had a turnover of Rs. 17.02 Cr in FY25, up from Rs. 0.93 Cr in FY24. No fresh funds are being infused — it is purely a debt-to-equity conversion of existing loans. Bhagiradha will continue to hold 100% in the subsidiary post-conversion. The move aims to reduce the subsidiary's interest burden, improve its debt-equity ratio, and support its growth and operational expansion.
This is an internal balance sheet restructuring with no change in ownership or fresh cash outflow. Shareholders are not diluted at the listed-entity level. For retail investors, it is largely neutral — the key thing to watch is whether the subsidiary's improving turnover translates into a stronger consolidated performance going forward.